Global Non-Invasive Prenatal Screening (NIPS) Market Growth (Status and Outlook) 2024-2031

Report ID: 1551647 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2028
        2.1.2 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Non-Invasive Prenatal Screening (NIPS) Segment by Type
        2.2.1 Trisomy 21
        2.2.2 Trisomy 18
        2.2.3 Trisomy 13
        2.2.4 Sex Chromosome Aneuploidies
        2.2.5 Others
    2.3 Non-Invasive Prenatal Screening (NIPS) Market Size by Type
        2.3.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
    2.4 Non-Invasive Prenatal Screening (NIPS) Segment by Application
        2.4.1 Clinical Laboratories
        2.4.2 Hospital
    2.5 Non-Invasive Prenatal Screening (NIPS) Market Size by Application
        2.5.1 Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
3 Non-Invasive Prenatal Screening (NIPS) Market Size by Player
    3.1 Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Players
        3.1.1 Global Non-Invasive Prenatal Screening (NIPS) Revenue by Players (2020-2022)
        3.1.2 Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Players (2020-2022)
    3.2 Global Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Non-Invasive Prenatal Screening (NIPS) by Regions
    4.1 Non-Invasive Prenatal Screening (NIPS) Market Size by Regions (2017-2022)
    4.2 Americas Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)
    4.3 APAC Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)
    4.4 Europe Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)
    4.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2017-2022)
    5.2 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)
    5.3 Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2017-2022)
    6.2 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)
    6.3 APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Non-Invasive Prenatal Screening (NIPS) by Country (2017-2022)
    7.2 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)
    7.3 Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) by Region (2017-2022)
    8.2 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022)
    8.3 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Non-Invasive Prenatal Screening (NIPS) Market Forecast
    10.1 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Regions (2023-2028)
        10.1.1 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Regions (2023-2028)
        10.1.2 Americas Non-Invasive Prenatal Screening (NIPS) Forecast
        10.1.3 APAC Non-Invasive Prenatal Screening (NIPS) Forecast
        10.1.4 Europe Non-Invasive Prenatal Screening (NIPS) Forecast
        10.1.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Forecast
    10.2 Americas Non-Invasive Prenatal Screening (NIPS) Forecast by Country (2023-2028)
        10.2.1 United States Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.2.2 Canada Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.2.3 Mexico Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.2.4 Brazil Non-Invasive Prenatal Screening (NIPS) Market Forecast
    10.3 APAC Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2023-2028)
        10.3.1 China Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.3.2 Japan Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.3.3 Korea Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.3.4 Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.3.5 India Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.3.6 Australia Non-Invasive Prenatal Screening (NIPS) Market Forecast
    10.4 Europe Non-Invasive Prenatal Screening (NIPS) Forecast by Country (2023-2028)
        10.4.1 Germany Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.4.2 France Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.4.3 UK Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.4.4 Italy Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.4.5 Russia Non-Invasive Prenatal Screening (NIPS) Market Forecast
    10.5 Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Forecast by Region (2023-2028)
        10.5.1 Egypt Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.5.2 South Africa Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.5.3 Israel Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.5.4 Turkey Non-Invasive Prenatal Screening (NIPS) Market Forecast
        10.5.5 GCC Countries Non-Invasive Prenatal Screening (NIPS) Market Forecast
    10.6 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Type (2023-2028)
    10.7 Global Non-Invasive Prenatal Screening (NIPS) Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Myriad Genetics
        11.1.1 Myriad Genetics Company Information
        11.1.2 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Offered
        11.1.3 Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Myriad Genetics Main Business Overview
        11.1.5 Myriad Genetics Latest Developments
    11.2 Illumina
        11.2.1 Illumina Company Information
        11.2.2 Illumina Non-Invasive Prenatal Screening (NIPS) Product Offered
        11.2.3 Illumina Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Illumina Main Business Overview
        11.2.5 Illumina Latest Developments
    11.3 Progenity
        11.3.1 Progenity Company Information
        11.3.2 Progenity Non-Invasive Prenatal Screening (NIPS) Product Offered
        11.3.3 Progenity Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 Progenity Main Business Overview
        11.3.5 Progenity Latest Developments
    11.4 Natera
        11.4.1 Natera Company Information
        11.4.2 Natera Non-Invasive Prenatal Screening (NIPS) Product Offered
        11.4.3 Natera Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 Natera Main Business Overview
        11.4.5 Natera Latest Developments
    11.5 Yourgene Health
        11.5.1 Yourgene Health Company Information
        11.5.2 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Offered
        11.5.3 Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Yourgene Health Main Business Overview
        11.5.5 Yourgene Health Latest Developments
    11.6 Roche Sequencing Solutions (RSS)
        11.6.1 Roche Sequencing Solutions (RSS) Company Information
        11.6.2 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Offered
        11.6.3 Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 Roche Sequencing Solutions (RSS) Main Business Overview
        11.6.5 Roche Sequencing Solutions (RSS) Latest Developments
    11.7 Eurofins LifeCodexx GmbH
        11.7.1 Eurofins LifeCodexx GmbH Company Information
        11.7.2 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Offered
        11.7.3 Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 Eurofins LifeCodexx GmbH Main Business Overview
        11.7.5 Eurofins LifeCodexx GmbH Latest Developments
    11.8 Labcorp
        11.8.1 Labcorp Company Information
        11.8.2 Labcorp Non-Invasive Prenatal Screening (NIPS) Product Offered
        11.8.3 Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Labcorp Main Business Overview
        11.8.5 Labcorp Latest Developments
    11.9 PerkinElmer
        11.9.1 PerkinElmer Company Information
        11.9.2 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Offered
        11.9.3 PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 PerkinElmer Main Business Overview
        11.9.5 PerkinElmer Latest Developments
    11.10 Harmony
        11.10.1 Harmony Company Information
        11.10.2 Harmony Non-Invasive Prenatal Screening (NIPS) Product Offered
        11.10.3 Harmony Non-Invasive Prenatal Screening (NIPS) Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 Harmony Main Business Overview
        11.10.5 Harmony Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Trisomy 21
    Table 3. Major Players of Trisomy 18
    Table 4. Major Players of Trisomy 13
    Table 5. Major Players of Sex Chromosome Aneuploidies
    Table 6. Major Players of Others
    Table 7. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)
    Table 9. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
    Table 10. Non-Invasive Prenatal Screening (NIPS) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)
    Table 12. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
    Table 13. Global Non-Invasive Prenatal Screening (NIPS) Revenue by Players (2020-2022) & ($ Millions)
    Table 14. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player (2020-2022)
    Table 15. Non-Invasive Prenatal Screening (NIPS) Key Players Head office and Products Offered
    Table 16. Non-Invasive Prenatal Screening (NIPS) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Non-Invasive Prenatal Screening (NIPS) Market Size by Regions 2017-2022 & ($ Millions)
    Table 20. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Regions (2017-2022)
    Table 21. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2017-2022) & ($ Millions)
    Table 22. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country (2017-2022)
    Table 23. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)
    Table 24. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
    Table 25. Americas Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)
    Table 26. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
    Table 27. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2017-2022) & ($ Millions)
    Table 28. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2017-2022)
    Table 29. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)
    Table 30. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
    Table 31. APAC Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)
    Table 32. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
    Table 33. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Country (2017-2022) & ($ Millions)
    Table 34. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country (2017-2022)
    Table 35. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)
    Table 36. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
    Table 37. Europe Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)
    Table 38. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
    Table 39. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Region (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region (2017-2022)
    Table 41. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Type (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type (2017-2022)
    Table 43. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size by Application (2017-2022) & ($ Millions)
    Table 44. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application (2017-2022)
    Table 45. Key Market Drivers & Growth Opportunities of Non-Invasive Prenatal Screening (NIPS)
    Table 46. Key Market Challenges & Risks of Non-Invasive Prenatal Screening (NIPS)
    Table 47. Key Industry Trends of Non-Invasive Prenatal Screening (NIPS)
    Table 48. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 49. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Regions (2023-2028)
    Table 50. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 51. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Type (2023-2028)
    Table 52. Global Non-Invasive Prenatal Screening (NIPS) Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 53. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share Forecast by Application (2023-2028)
    Table 54. Myriad Genetics Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
    Table 55. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Product Offered
    Table 56. Myriad Genetics Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 57. Myriad Genetics Main Business
    Table 58. Myriad Genetics Latest Developments
    Table 59. Illumina Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
    Table 60. Illumina Non-Invasive Prenatal Screening (NIPS) Product Offered
    Table 61. Illumina Main Business
    Table 62. Illumina Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 63. Illumina Latest Developments
    Table 64. Progenity Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
    Table 65. Progenity Non-Invasive Prenatal Screening (NIPS) Product Offered
    Table 66. Progenity Main Business
    Table 67. Progenity Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 68. Progenity Latest Developments
    Table 69. Natera Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
    Table 70. Natera Non-Invasive Prenatal Screening (NIPS) Product Offered
    Table 71. Natera Main Business
    Table 72. Natera Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 73. Natera Latest Developments
    Table 74. Yourgene Health Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
    Table 75. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Product Offered
    Table 76. Yourgene Health Main Business
    Table 77. Yourgene Health Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 78. Yourgene Health Latest Developments
    Table 79. Roche Sequencing Solutions (RSS) Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
    Table 80. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Product Offered
    Table 81. Roche Sequencing Solutions (RSS) Main Business
    Table 82. Roche Sequencing Solutions (RSS) Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 83. Roche Sequencing Solutions (RSS) Latest Developments
    Table 84. Eurofins LifeCodexx GmbH Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
    Table 85. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Product Offered
    Table 86. Eurofins LifeCodexx GmbH Main Business
    Table 87. Eurofins LifeCodexx GmbH Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 88. Eurofins LifeCodexx GmbH Latest Developments
    Table 89. Labcorp Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
    Table 90. Labcorp Non-Invasive Prenatal Screening (NIPS) Product Offered
    Table 91. Labcorp Main Business
    Table 92. Labcorp Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 93. Labcorp Latest Developments
    Table 94. PerkinElmer Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
    Table 95. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Product Offered
    Table 96. PerkinElmer Main Business
    Table 97. PerkinElmer Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 98. PerkinElmer Latest Developments
    Table 99. Harmony Details, Company Type, Non-Invasive Prenatal Screening (NIPS) Area Served and Its Competitors
    Table 100. Harmony Non-Invasive Prenatal Screening (NIPS) Product Offered
    Table 101. Harmony Main Business
    Table 102. Harmony Non-Invasive Prenatal Screening (NIPS) Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 103. Harmony Latest Developments
List of Figures
    Figure 1. Non-Invasive Prenatal Screening (NIPS) Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Non-Invasive Prenatal Screening (NIPS) Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2021
    Figure 7. Non-Invasive Prenatal Screening (NIPS) in Clinical Laboratories
    Figure 8. Global Non-Invasive Prenatal Screening (NIPS) Market: Clinical Laboratories (2017-2022) & ($ Millions)
    Figure 9. Non-Invasive Prenatal Screening (NIPS) in Hospital
    Figure 10. Global Non-Invasive Prenatal Screening (NIPS) Market: Hospital (2017-2022) & ($ Millions)
    Figure 11. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021
    Figure 12. Global Non-Invasive Prenatal Screening (NIPS) Revenue Market Share by Player in 2021
    Figure 13. Global Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Regions (2017-2022)
    Figure 14. Americas Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)
    Figure 15. APAC Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)
    Figure 16. Europe Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)
    Figure 17. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2017-2022 ($ Millions)
    Figure 18. Americas Non-Invasive Prenatal Screening (NIPS) Value Market Share by Country in 2021
    Figure 19. Americas Non-Invasive Prenatal Screening (NIPS) Consumption Market Share by Type in 2021
    Figure 20. Americas Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021
    Figure 21. United States Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 22. Canada Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 23. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 25. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2021
    Figure 26. APAC Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021
    Figure 27. China Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 28. Japan Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 29. Korea Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 31. India Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Australia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 33. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Country in 2021
    Figure 34. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2021
    Figure 35. Europe Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021
    Figure 36. Germany Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 37. France Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 38. UK Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 39. Italy Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 40. Russia Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Region in 2021
    Figure 42. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Type in 2021
    Figure 43. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size Market Share by Application in 2021
    Figure 44. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 45. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 46. Israel Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 47. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 48. GCC Country Non-Invasive Prenatal Screening (NIPS) Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Americas Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 50. APAC Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 51. Europe Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 52. Middle East & Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 53. United States Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 54. Canada Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 55. Mexico Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 56. Brazil Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 57. China Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 58. Japan Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 59. Korea Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 60. Southeast Asia Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 61. India Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 62. Australia Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 63. Germany Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 64. France Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 65. UK Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 66. Italy Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 67. Russia Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 68. Spain Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 69. Egypt Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 70. South Africa Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 71. Israel Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 72. Turkey Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
    Figure 73. GCC Countries Non-Invasive Prenatal Screening (NIPS) Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Non-Invasive Prenatal Screening Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Non-Invasive Prenatal Screening Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Non-Invasive Prenatal Screening Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports